In terms of valuation, Mira Pharmaceuticals Inc’s market capitalization stands at $15.52 million. Market cap represents the total value of all outstanding shares and is a key indicator of a company’s ...
MIRA READ THE FULL MIRA RESEARCH REPORT MIRA Pharmaceuticals (NASDAQ:MIRA) is a preclinical-stage pharmaceutical company focused on the development and commercialization of a new molecular synthetic ...
The Wilson facility was originally built in 1994 by pharmaceutical manufacturer Novopharm, which later became Teva Pharmaceuticals. The site, an anchor of the Wilson Corporate Park, faces neighboring ...